GSK China
WEB葛兰素史克作为一家全球生物医药公司，以“汇聚科学、技术与人才，合力超越，共克疾病”为我们的愿景和使命。 使命、战略和文化. 我们是GSK. 2：47. 我们的战略. 我们推出一系列创新的疫苗、特药和普药来预防并治疗疾病。 同时运用免疫系统科学、人类遗传学和前沿技术的研发方式。 我们的研发专注于四大治疗领域：传染性疾病、HIV、呼吸系统疾病/免疫学、肿瘤学。 使命、战略和文化. 传染性疾病. 1/3. 一生中会得带状疱疹的人数. 访问全球传 …
GSK pumps $29M into infectious disease R&D hub in Beijing
WEBMar 31, 2016 · GlaxoSmithKline will pump in $29 million for a Beijing-based R&D institute to tackle infectious disease and antibiotic resistance health threats in China by working in tandem with academics...
GlaxoSmithKline (China) Investment Co.,Ltd Company Profile | Beijing …
WEBFind company research, competitor information, contact details & financial data for GlaxoSmithKline (China) Investment Co.,Ltd of Beijing, Beijing. Get the latest business insights from Dun & Bradstreet.
British executive accused in China drug bribery | AP News
WEBMay 14, 2014 · BEIJING (AP) — Chinese police Wednesday accused a British executive of GlaxoSmithKline of leading a sprawling scheme to bribe doctors and hospitals to use its drugs. The announcement was the first time a foreign employee in China of British-based GSK was accused in the investigation announced last July.
GSK and Zhifei announce exclusive strategic vaccine partnership in ...
WEBOct 9, 2023 · GSK and Zhifei, the largest Chinese vaccine company, will co-promote Shingrix, GSK's shingles vaccine, and potentially co-develop Arexvy, GSK's RSV vaccine for older adults in China. The partnership aims to expand access to innovative vaccines and support GSK's global sales goals.
China fines GlaxoSmithKline $492M for bribery | AP News
WEBSep 19, 2014 · BEIJING (AP) — Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China, the biggest such penalty ever imposed by a Chinese court. The court sentenced the company’s former China manager, Briton Mark Reilly, and four Chinese co-defendants to prison but postponed the …
Viewpoint: Why is China investigating GlaxoSmithKline?
WEBAug 6, 2013 · The corruption investigation launched by the Chinese authorities against GlaxoSmithKline (GSK) continues to pass like a whirlwind through the firm's Chinese operations, throwing into chaos the...
China blocks Glaxo executive from leaving the country
WEBJul 17, 2013 · Pharmaceutical giant GlaxoSmithKline revealed more bad news Wednesday, disclosing that Beijing officials have barred GSK's head of finance for China from leaving the country amid accusations...
GSK signs £2.5bn shingles vaccine deal with China’s Zhifei
WEBOct 9, 2023 · GSK has signed a deal with Zhifei, China’s largest vaccine company by revenue, as the British drugmaker aims to double global sales of its shingles vaccine by 2026.
GSK breathes hope into respiratory biz in country
WEBAug 20, 2024 · Global biopharmaceutical company GlaxoSmithKline is scheduled to submit market approvals in China for about 15 new drugs and indications over the next three years and more than 20 clinical research projects will be conducted in the country, said a senior executive of the company.